User:Paul Anders Fronth Nyhus: Difference between revisions
Line 28: | Line 28: | ||
==Useful links== | ==Useful links== | ||
http://www.cdc.gov/OD/ohs/biosecurity_training/ | |||
http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm | |||
*[[OpenWetWare:Welcome|Introductory tutorial]] | *[[OpenWetWare:Welcome|Introductory tutorial]] | ||
*[[Help|OpenWetWare help pages]] | *[[Help|OpenWetWare help pages]] | ||
Line 37: | Line 40: | ||
One of the major challenges ahead is Antibiotics resistance | One of the major challenges ahead is Antibiotics resistance | ||
How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/ | How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/ | ||
Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ? http://www.gmo-compass.org | Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ? | ||
http://www.gmo-compass.org | |||
http://www.who.int/drugresistance/whonetsoftware/en/ | http://www.who.int/drugresistance/whonetsoftware/en/ | ||
http://www.fda.gov/Fdac/features/795_antibio.html | http://www.fda.gov/Fdac/features/795_antibio.html | ||
http://www.who.int/mediacentre/factsheets/fs194/en/ | http://www.who.int/mediacentre/factsheets/fs194/en/ |
Revision as of 15:17, 11 February 2009
I am a new member of OpenWetWare!
Contact Info
- Paul Anders Fronth Nyhus
- NorBioS@mac.com
- Europe
- Email me through OpenWetWare
I work in the [Open LAB ] at XYZ University. I learned about OpenWetWare from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a framework and voluntary code of conduct for dealing proactively with Biorisks , Biosafety , Biosecurity and Biodiversity issues in Synthetic Biology and Combinatorial Genomics .Herein included Economic, Ethical, Legal and Social Issues as to maximize benefits ( for whom ? ) and minimize potential negative risks and unintended consequences if not sheer luddism and complete rejection from civil society.
Discussing the options by inclusion and involvement of stakeholders sui generis:
Education
- Year, PhD, Institute
- Year, MS, Institute
- Year, BS, Institute
Research interests
- Comparative genomics of Aquaporins
- Comparative genomics proteomics and metabolomics of Photosynthsis /E-Photosynthesis
- Comparative genomics of gene regulatory networks
- Evolution & Development & Ecology ( Evo Devo Evo Framework as applied to biology and to technology : Biomimetics &BioTriz)
- Converging technologies ( Bits Atoms Nurons & Genes )
Useful links
http://www.cdc.gov/OD/ohs/biosecurity_training/ http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm
- Introductory tutorial
- OpenWetWare help pages
- http://www.biosecuritycodes.org/
- http://www.synbiosafe.eu/
- http://www.biosafety.be/Menu/BiosEur.html
- http://www.patentlens.net/daisy/patentlens/patentlens.html
- http://www.opbw.org/
One of the major challenges ahead is Antibiotics resistance How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/ Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ? http://www.gmo-compass.org http://www.who.int/drugresistance/whonetsoftware/en/ http://www.fda.gov/Fdac/features/795_antibio.html http://www.who.int/mediacentre/factsheets/fs194/en/